Next Article in Journal
Identification of Mutations in Antimalarial Resistance Gene Kelch13 from Plasmodium falciparum Isolates in Kano, Nigeria
Next Article in Special Issue
Performance of an Automated Zika IgG Immunoassay in the Detection of Zika IgG Specific Antibodies—A Validation Approach in Samples from Prevalence Areas and Non-Endemic Countries
Previous Article in Journal
Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India
Previous Article in Special Issue
Spatiotemporal and Socioeconomic Risk Factors for Dengue at the Province Level in Vietnam, 2013–2015: Clustering Analysis and Regression Model
Article

Monitoring Insecticide Susceptibility in Aedes Aegypti Populations from the Two Biggest Cities, Ouagadougou and Bobo-Dioulasso, in Burkina Faso: Implication of Metabolic Resistance

1
Institut de Recherche en Sciences de la Santé (IRSS), Bobo-Dioulasso BP 545, Burkina Faso
2
Département des Sciences Biomédicales, Centre Muraz, Bobo-Dioulasso BP 390, Burkina Faso
3
Institut Supérieur des Sciences de la Santé, Université Nazi Boni, Bobo-Dioulasso BP 1091, Burkina Faso
4
Département de Biologie et de Physiologie Animales, Université Joseph Ki-Zerbo, Ouagadougou BP 7021, Burkina Faso
5
Unité de Formation et de Recherche en Sciences et Techniques, Université Norbert Zongo, Koudougou BP 376, Burkina Faso
6
Maladies Infectieuses et Vecteurs: Écologie et Contrôle (MIVEGEC), Univ Montpellier, CNRS, IRD, 34394 Montpellier, France
*
Authors to whom correspondence should be addressed.
Namountougou Moussa and Soma Diloma Dieudonné contributed equally to this work.
These authors contributed equally to this work.
Trop. Med. Infect. Dis. 2020, 5(2), 84; https://doi.org/10.3390/tropicalmed5020084
Received: 12 January 2020 / Revised: 26 February 2020 / Accepted: 28 February 2020 / Published: 27 May 2020
(This article belongs to the Special Issue Epidemiology of Dengue: Past, Present and Future (Volume II))
In West Africa, Aedes aegypti remains the major vector of dengue virus. Since 2013, dengue fever has been reemerging in Burkina Faso with annual outbreaks, thus becoming a major public health problem. Its control relies on vector control, which is unfortunately facing the problem of insecticide resistance. At the time of this study, although data on phenotypic resistance were available, information related to the metabolic resistance in Aedes populations from Burkina Faso remained very scarce. Here, we assessed the phenotypic and the metabolic resistance of Ae. aegypti populations sampled from the two main urban areas (Ouagadougou and Bobo-Dioulasso) of Burkina Faso. Insecticide susceptibility bioassays to chlorpyriphos-methyl 0.4%, bendiocarb 0.1% and deltamethrin 0.05% were performed on natural populations of Ae. aegypti using the WHO protocol. The activity of enzymes involved in the rapid detoxification of insecticides, especially non-specific esterases, oxidases (cytochrome P450) and glutathione-S-transferases, was measured on individual mosquitos. The mortality rates for deltamethrin 0.05% were low and ranged from 20.72% to 89.62% in the Bobo-Dioulasso and Ouagadougou sites, respectively. When bendiocarb 0.1% was tested, the mortality rates ranged from 7.73% to 71.23%. Interestingly, in the two urban areas, mosquitoes were found to be fully susceptible to chlorpyriphos-methyl 0.4%. Elevated activity of non-specific esterases and glutathione-S-transferases was reported, suggesting multiple resistance mechanisms involved in Ae. aegypti populations from Bobo-Dioulasso and Ouagadougou (including cytochrome P450). This update to the insecticide resistance status within Ae. aegypti populations in the two biggest cities is important to better plan dengue vectors control in the country and provides valuable information for improving vector control strategies in Burkina Faso, West Africa. View Full-Text
Keywords: Aedes aegypti; dengue; insecticide susceptibility; metabolic resistance; Burkina Faso Aedes aegypti; dengue; insecticide susceptibility; metabolic resistance; Burkina Faso
Show Figures

Figure 1

MDPI and ACS Style

Namountougou, M.; Soma, D.D.; Balboné, M.; Kaboré, D.A.; Kientega, M.; Hien, A.; Coulibaly, A.; Ouattara, P.E.; Meda, B.G.; Drabo, S.; Koala, L.; Nignan, C.; Kagoné, T.; Diabaté, A.; Fournet, F.; Gnankiné, O.; Dabiré, R.K. Monitoring Insecticide Susceptibility in Aedes Aegypti Populations from the Two Biggest Cities, Ouagadougou and Bobo-Dioulasso, in Burkina Faso: Implication of Metabolic Resistance. Trop. Med. Infect. Dis. 2020, 5, 84. https://doi.org/10.3390/tropicalmed5020084

AMA Style

Namountougou M, Soma DD, Balboné M, Kaboré DA, Kientega M, Hien A, Coulibaly A, Ouattara PE, Meda BG, Drabo S, Koala L, Nignan C, Kagoné T, Diabaté A, Fournet F, Gnankiné O, Dabiré RK. Monitoring Insecticide Susceptibility in Aedes Aegypti Populations from the Two Biggest Cities, Ouagadougou and Bobo-Dioulasso, in Burkina Faso: Implication of Metabolic Resistance. Tropical Medicine and Infectious Disease. 2020; 5(2):84. https://doi.org/10.3390/tropicalmed5020084

Chicago/Turabian Style

Namountougou, Moussa, Dieudonné D. Soma, Mahamoudou Balboné, Didier A. Kaboré, Mahamadi Kientega, Aristide Hien, Ahmed Coulibaly, Parfait E. Ouattara, Benson G. Meda, Samuel Drabo, Lassane Koala, Charles Nignan, Thérèse Kagoné, Abdoulaye Diabaté, Florence Fournet, Olivier Gnankiné, and Roch K. Dabiré. 2020. "Monitoring Insecticide Susceptibility in Aedes Aegypti Populations from the Two Biggest Cities, Ouagadougou and Bobo-Dioulasso, in Burkina Faso: Implication of Metabolic Resistance" Tropical Medicine and Infectious Disease 5, no. 2: 84. https://doi.org/10.3390/tropicalmed5020084

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop